TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Active Biotech AB ( (SE:ACTI) ) has shared an update.
Active Biotech AB has announced an Extraordinary General Meeting to discuss significant changes, including amendments to the Articles of Association and a new share issue. The proposed changes aim to increase the company’s share capital and authorize the Board to issue new shares, potentially impacting the company’s financial structure and attracting new investors.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer.
YTD Price Performance: 44.44%
Average Trading Volume: 4,892,505
Technical Sentiment Signal: Sell
Current Market Cap: SEK192.6M
See more data about ACTI stock on TipRanks’ Stock Analysis page.